Innovative Zelltherapie auf Stammzellbasis zur Regeneration von Knorpel im Knie. Klinisch geprüft und minimal invasiv.
Location: Germany, Saxony, Grimma
Investors 1
| Date | Name | Website |
| 01.11.2024 | bm-t betei... | bm-t.de |
Mentions in press and media 2
| Date | Title | Description |
| 08.05.2025 | BIONCaRT receives approval to conduct a clinical trial with stem cells for the treatment of cartilage damage in the knee joint | BIONCaRT GmbH has received approval to conduct a clinical phase I/IIa study from the responsible national higher federal authority, the Paul Ehrlich Institute. The aim of the study is to investigate the safety and initial indic... |
| 21.08.2024 | BioPlanta becomes BIONCaRT — bm|t, TGFS, private investors and founders jointly invest a seven-figure sum to conduct a clinical trial | bm|t beteiligungsmanagement thüringen (bm|t), TGFS Technologiegründerfonds Sachsen, private investors and the founder are investing a seven-figure sum in BIONCaRT GmbH (formerly BioPlanta GmbH) in a seed financing round. Th... |